A. M. Galustov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
A. M. Galustov has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Denis I. Sofronov
N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia
4 shared publications - Alexandra Fedorova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
3 shared publications - Aslan Kamraddinovich Valiev
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
2 shared publications - K. N. Magomedova
N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
2 shared publications - Kirill Aleksandrovich Borzov
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
2 shared publications - Nikita S. Babkin
N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
2 shared publications
Latest Publications
- Open Access
- 14 October 2025
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 17 (3) , 57-67
Safety and efficacy of radiofrequency ablation in desmoid-type fibromatosis
Introduction. Desmoid-type fibromatosis is a rare locally aggressive tumor originating in connective tissue and characterized by locally destructive invasive growth, high recurrence potential and absence of metastases. In recent years, attempts to standardize the treatment of this disease were made but all current therapy methods have disadvantages and do not guarantee absence of disease progression. Aim. To evaluate safety and efficacy of radiofrequency ablation in patients with desmoid tumors. Materials and methods. The study included 9 adult patients of both genders (4 men and 5 women) aged 21–65 years with morphologically verified diagnosis of desmoid tumor of the soft tissues with extra-abdominal location. All patients in the study group underwent control examination prior to the procedure. The treatment was performed in several stages at low volume (2–50 cm3) taking into account tumor size. Efficacy was determined using pain syndrome regression per the VAS and Watkins scale, as well as Karnofsky Performance Status Scale. Safety was evaluated per the Clavien–Dindo Scale. Results. Analysis of pain syndrome dynamics per the VAS and Watkins scale before and after treatment was performed. For both VAS (p = 0.004) and Watkins scale (p = 0.014), statistically significant changes were observed. Pain syndrome decreased to 50 %, and the percentage of patients declining analgesics increased to 66.7 %. Analysis of the performance status per the Karnofsky scale also showed statistically significant changes (p = 0.015). Mean value increased to 90 %. No complications were reported at the time of the study. Conclusion. Radiofrequency ablation showed itself to be a safe and effective method for treatment of desmoid tumors. However, further studies are necessary involving more patients.
- 14 October 2025
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 17 (3) , 57-67
Open AccessSafety and efficacy of radiofrequency ablation in desmoid-type fibromatosis
Introduction. Desmoid-type fibromatosis is a rare locally aggressive tumor originating in connective tissue and characterized by locally destructive invasive growth, high recurrence potential and absence of metastases. In recent years, attempts to standardize the treatment of this disease were made but all current therapy methods have disadvantages and do not guarantee absence of disease progression. Aim. To evaluate safety and efficacy of radiofrequency ablation in patients with desmoid tumors. Materials and methods. The study included 9 adult patients of both genders (4 men and 5 women) aged 21–65 years with morphologically verified diagnosis of desmoid tumor of the soft tissues with extra-abdominal location. All patients in the study group underwent control examination prior to the procedure. The treatment was performed in several stages at low volume (2–50 cm3) taking into account tumor size. Efficacy was determined using pain syndrome regression per the VAS and Watkins scale, as well as Karnofsky Performance Status Scale. Safety was evaluated per the Clavien–Dindo Scale. Results. Analysis of pain syndrome dynamics per the VAS and Watkins scale before and after treatment was performed. For both VAS (p = 0.004) and Watkins scale (p = 0.014), statistically significant changes were observed. Pain syndrome decreased to 50 %, and the percentage of patients declining analgesics increased to 66.7 %. Analysis of the performance status per the Karnofsky scale also showed statistically significant changes (p = 0.015). Mean value increased to 90 %. No complications were reported at the time of the study. Conclusion. Radiofrequency ablation showed itself to be a safe and effective method for treatment of desmoid tumors. However, further studies are necessary involving more patients.
- 17 April 2025
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 17 (1)
The first experience of total sacral endoprothesis with an individual implant after total sacrectomy (a rare clinical case)
Bone sarcomas are one the rarest types of malignant tumors comprising only 0.2–1 % of oncological diseases. Chondrosarcoma is the 3rd most common bone sarcoma. This tumor is characterized by low sensitivity to drug and radiological treatment. According to literature data, the current golden standard of bone chondrosarcoma treatment is en bloc radical surgical resection with preservation of clean resection margins. However, common for this tumor location in the pelvic bones can pose difficulties at the stage of surgical planning.The article presents a clinical case of surgical treatment of sacrum G2 chondrosarcoma in the volume of total sacrectomy with defect replacement using a personalized implant manufactured using a 3D printer and with lumbosacral stabilization.
- 17 April 2025
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 17 (1)
The first experience of total sacral endoprothesis with an individual implant after total sacrectomy (a rare clinical case)
Bone sarcomas are one the rarest types of malignant tumors comprising only 0.2–1 % of oncological diseases. Chondrosarcoma is the 3rd most common bone sarcoma. This tumor is characterized by low sensitivity to drug and radiological treatment. According to literature data, the current golden standard of bone chondrosarcoma treatment is en bloc radical surgical resection with preservation of clean resection margins. However, common for this tumor location in the pelvic bones can pose difficulties at the stage of surgical planning.The article presents a clinical case of surgical treatment of sacrum G2 chondrosarcoma in the volume of total sacrectomy with defect replacement using a personalized implant manufactured using a 3D printer and with lumbosacral stabilization.
- Open Access
- 1 July 2023
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 15 (2) , 46-52
Hibernoma: a case report and discussion of a rare tumor
Intriduction. Hibernomas account for less than 2 % of all benign lipomatous tumors and 1 % of all lipomatous tumors. They are usually found in 20–40-year old adults (the average age of patients is 38 years). The clinical manifestations are painless soft tissue mass that are mostly slow growing; rapid growth is only found in a small number of patients. We present a case of successful surgical treatment of a pathologically confirmed rare lipomatous tumor of large size, which was located in the soft tissues of the thigh.Clinical case. A 46-year-old woman was admitted to the hospital due to a tumor 20 × 10 × 10 cm in size, that had developed 10 years ago in the anteromedial aspect of the proximal thigh. Furthermore, she had a history of hypoesthesia one month prior to her admission. During surgery, the femoral nerve was found to be compressed by the large tumor. The resultant symptoms probably caused the patient to seek medical care. Resection was performed by careful dissection, femoral nerve and vessels were spared. Histopathological examination and cytogenetics showed findings suggestive of a hibernoma. At the 6-month follow-up local tumor recurrence or metastasis was not found.Conclusions. Asymptomatic small-sized hibernoma does not require surgical resection or other treatment. When the tumor is too large and/or has the potential to compress the surrounding tissues, timely radical surgical intervention is reuired.
- 1 July 2023
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 15 (2) , 46-52
Open AccessHibernoma: a case report and discussion of a rare tumor
Intriduction. Hibernomas account for less than 2 % of all benign lipomatous tumors and 1 % of all lipomatous tumors. They are usually found in 20–40-year old adults (the average age of patients is 38 years). The clinical manifestations are painless soft tissue mass that are mostly slow growing; rapid growth is only found in a small number of patients. We present a case of successful surgical treatment of a pathologically confirmed rare lipomatous tumor of large size, which was located in the soft tissues of the thigh.Clinical case. A 46-year-old woman was admitted to the hospital due to a tumor 20 × 10 × 10 cm in size, that had developed 10 years ago in the anteromedial aspect of the proximal thigh. Furthermore, she had a history of hypoesthesia one month prior to her admission. During surgery, the femoral nerve was found to be compressed by the large tumor. The resultant symptoms probably caused the patient to seek medical care. Resection was performed by careful dissection, femoral nerve and vessels were spared. Histopathological examination and cytogenetics showed findings suggestive of a hibernoma. At the 6-month follow-up local tumor recurrence or metastasis was not found.Conclusions. Asymptomatic small-sized hibernoma does not require surgical resection or other treatment. When the tumor is too large and/or has the potential to compress the surrounding tissues, timely radical surgical intervention is reuired.
- Open Access
- 28 August 2021
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 13 (2) , 18-25
Modern approach to the treatment of sacrococcygeal chordomas
Chordomas of the sacrococcygeal region account for more than 50 % of all sacral tumors. These malignant neoplasms grow slowly and are asymptomatic for a long time. As a result, chordomas often reach large sizes and affect the neurovascular structures of the sacrum and pelvic organs. The use of en-bloc resection allows to increase survival rates and reduce the risk of progression. However, this method of chord treatment is difficult for surgeons and in most cases, after surgery, the quality of life of patients decreases. The improvement of imaging methods, the success of oncological orthopedics and radiation therapy allow performing radical organ-preserving operations. In this article, we will consider the modern concept of treatment with a sacrococcygeal chord.
- 28 August 2021
- Published by Publishing House ABV Press in Bone and soft tissue sarcomas, tumors of the skin
- Vol. 13 (2) , 18-25
Open AccessModern approach to the treatment of sacrococcygeal chordomas
Chordomas of the sacrococcygeal region account for more than 50 % of all sacral tumors. These malignant neoplasms grow slowly and are asymptomatic for a long time. As a result, chordomas often reach large sizes and affect the neurovascular structures of the sacrum and pelvic organs. The use of en-bloc resection allows to increase survival rates and reduce the risk of progression. However, this method of chord treatment is difficult for surgeons and in most cases, after surgery, the quality of life of patients decreases. The improvement of imaging methods, the success of oncological orthopedics and radiation therapy allow performing radical organ-preserving operations. In this article, we will consider the modern concept of treatment with a sacrococcygeal chord.